title: Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit.
abstract: BACKGROUND
  Squamous cell carcinomas of the head and neck region (HNSCC) are among the most common malignancies in this area. The VX2 carcinoma of the New Zealand white rabbit metastasizes lymphatically as is the case in HNSCC and therefore, potentially, could be used as a model for HNSCC. Since the family of matrix-metalloproteinases (MMPs) is involved in the process of HNSCC invasion, the aim of this study was to investigate the expression level of MMPs and their specific inhibitors (TIMPs) in the VX2 carcinoma to evaluate if they also play a role in VX2 tumor invasion as observed in human HNSCC.
  
  
  METHODS
  The VX2 carcinoma was generated by tumor implantation in the rabbit's ear as previously described. Western blots were performed under standard conditions, utilizing antibodies against MMP-3, MMP-13, TIMP-2 and TIMP-3. Immunohistochemical staining was performed with the ABC-complex method.
  
  
  RESULTS
  A positive immunohistochemical signal could be detected for MMP-3, TIMP-2 and TIMP-3 with no significant signal for MMP-13. In the Western blots immunoreactive bands could be observed for MMP-3, MMP-13, TIMP-2 and TIMP-3.
  
  
  CONCLUSIONS
  MMP-3, MMP-13, TIMP-2 and TIMP-3 were found to be expressed in VX2 carcinomas of the New Zealand white rabbits. The VX2 carcinoma therefore resembles HNSCC tumors not only in its metastatic behavior, but also regarding the expression of MMPs and TIMPs, which are the probable keyplayers during the event of invasion. These observations further underline the significance of the VX2 carcinoma as a model tumor of human HNSCC.
authors.affiliation: Department of Otorhinolaryngology, Philipps University, Deutschhausstr. 3, 35037 Marburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Mandic
authors.forename: A A
authors.initials: AA
authors.lastname: Dünne
authors.forename: N
authors.initials: N
authors.lastname: Eikelkamp
authors.forename: A
authors.initials: A
authors.lastname: Ramaswamy
authors.forename: S
authors.initials: S
authors.lastname: Schulz
authors.forename: A
authors.initials: A
authors.lastname: Teymoortash
authors.forename: A
authors.initials: A
authors.lastname: Sesterhenn
authors.forename: R
authors.initials: R
authors.lastname: Moll
authors.forename: J A
authors.initials: JA
authors.lastname: Werner
mesh_terms: D000818:Animals; D002277:Carcinoma / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology; D017364:Collagenases / Q000096:biosynthesis*; D004195:Disease Models, Animal; D004428:Ear Neoplasms / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D006258:Head and Neck Neoplasms / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D053509:Matrix Metalloproteinase 13; D019278:Matrix Metalloproteinase 3 / Q000096:biosynthesis*; D011817:Rabbits; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000096:biosynthesis*; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000096:biosynthesis*
chemical_list: D019717:Tissue Inhibitor of Metalloproteinase-3; D019716:Tissue Inhibitor of Metalloproteinase-2; D017364:Collagenases; C507079:MMP13 protein, human; D053509:Matrix Metalloproteinase 13; D019278:Matrix Metalloproteinase 3